A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
about
Fungal allergy in asthma-state of the art and research needsAntifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosisAntifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosisAzoles for allergic bronchopulmonary aspergillosis associated with asthmaAzoles for allergic bronchopulmonary aspergillosis associated with asthmaHigh-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal diseaseManagement of allergic bronchopulmonary aspergillosis: a review and updateBronchiectasis and Aspergillus: How are they linked?IgE in the diagnosis and treatment of allergic disease.Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis.The role of allergy in severe asthma.Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the LiteratureUncontrolled asthma and recurring pulmonary opacities: just asthma?Aspergillus infections in transplant recipients.Respiratory tract allergic disease and atopy: experimental evidence for a fungal infectious etiologyPractice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.Effectiveness of itraconazole on clinical symptoms and radiologic findings in patients with recurrent chronic rhinosinusitis and nasal polyposisAllergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment.Rationale for combination antifungal therapy.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.Clinical hepatotoxicity associated with antifungal agents.Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution.Potential contribution of fungal infection and colonization to the development of allergy.Aspergillus fumigatus and related species.Recommendations for the treatment of fungal pneumonias.Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal RhinosinusitisTreatment of paediatric non-cystic fibrosis bronchiectasis.Eosinophilic pneumonias.A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.Pulmonary Schizophyllum commune infection developing mucoid impaction of the bronchi.Central airways obstruction due to Aspergillus fumigatus after lung transplantationAdvances in management of paranasal sinus aspergillosis.Pharmacotherapy for bronchiectasis.Aspergillus-associated airway disease, inflammation, and the innate immune responseToward a comprehensive understanding of allergic lung disease.Prevalence of Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma at a tertiary care center in North India.An unusual cause of lung mass in a young femaleOrgan-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract.The role of anti-infectives in the treatment of refractory asthma.
P2860
Q22001138-821F0CE7-CAB8-400B-8C97-097990F72E6CQ24187765-00A18CF5-9EA3-4047-B0CF-E01F33ACB0C8Q24202783-4447772B-0522-449F-B192-66E226BB7B2AQ24246695-208383C0-764D-414B-9653-82548479DB28Q24250156-F583264F-BDE4-4932-9C15-B0D7607C426CQ24628838-986D3A0A-02EE-47E3-BBC3-99EE978BCDA9Q28265740-F6340F1B-F591-4CEC-B737-234BC7BB58D0Q30243947-02AF0882-E1C7-414A-9367-3EB39E142558Q30276662-02C37E4D-4BE6-4E6D-9649-36092E9C2304Q30355164-B7E5492A-B3B7-4265-81B0-3C6DA9181455Q30419500-FE45A097-4001-4C84-BC5D-8B186D001595Q33641883-01EE8692-9123-4948-8140-C2279766EC01Q33691443-6CDD9062-58F5-42F0-BC21-5CF076EEFD1FQ33719294-0DB1E294-380C-42E5-A844-06934A2E4643Q33836310-7BF3DA4A-6529-471C-AB99-51A21F2DFF85Q33894472-A19857A4-2029-4460-A048-4AB8C042FEE8Q34169948-D36A84C9-139C-4E41-8647-B114A2AA5177Q34192961-9A876B67-DF7E-417A-810B-5F056EBBA868Q34335236-3F5D2CE1-BF05-4B7B-B103-6D1DF050EDEAQ34532546-4E7AE7CF-8E33-453D-B3FB-C4730DBCC59FQ34535033-6047F7D7-64C8-482D-A748-11F36D9A5D24Q34546811-2687592C-086F-4009-B28D-2112F92AC9C9Q34719251-D086A3BD-27B5-4727-90E6-0A51ADA487FBQ34977170-277F8D39-B586-4E2F-B625-DF5C915607B1Q35045054-EAF47FF5-0F16-473A-8251-5DBFA58ACD54Q35183728-7E31D754-4075-4394-8B88-D5F3F7B981C7Q35543734-C2EE01F5-6A49-459C-80BC-021C4B248439Q35814394-AB42E8CE-178E-47A3-91AF-4EEFA1785BB6Q36149065-31A1C027-59E1-4D33-8FA3-0047598AAF88Q36388027-2443D266-FD10-4061-BD34-0FD7341ADEE2Q36470394-0EDE8582-1A5F-46DE-8B48-E3E1117BFE7BQ36655481-0212D49F-DF6A-4F84-A6DD-78840F5B1510Q36968480-C54FA191-6995-442D-8328-D17063B1BBAEQ37013047-45B52703-56B5-44E8-A4FC-A42669D0A79FQ37077782-DD1D642C-30C9-4189-9BE9-6F33917A0639Q37348221-BCD7E155-FA1F-4332-B4A5-7E43E1534A48Q37701190-4BF0B3BF-3028-4CA1-A36B-81DB2F3A6F1AQ37723371-23767248-0EEE-466C-8D7E-54388FF637E5Q37731037-F23C1519-9494-4250-BE70-2FE2D0CB1180Q37860762-4A39AAE3-605A-413D-8232-AD0AFC891C21
P2860
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
@en
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
@nl
type
label
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
@en
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
@nl
prefLabel
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
@en
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
@nl
P2093
P1476
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
@en
P2093
Bamberger DM
Catanzaro A
DeGraff AC Jr
Moskovitz BL
Platts-Mills TA
Schwartz HJ
Stevens DA
P304
P356
10.1056/NEJM200003163421102
P407
P577
2000-03-01T00:00:00Z